Clinical Trial Update: Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of combining alogliptin with pioglitazone in Type 2 diabetes mellitus. Results were posted after study completion in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• Nesina (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-04-04